Literature DB >> 18048871

The role of hemodynamic measurements in the management of venous and ischemic ulcers.

M K Lazarides1, A D Giannoukas.   

Abstract

There is a need for quantitative investigations in the vascular laboratory to manage lower extremity ulcers. The majority of leg ulcers are of venous (45%-60%) or arterial origin (10%-20%). Despite the increasing complexity of new devices used in vascular surgical practice, the anklebrachial pressure index (ABPI) remains the cornerstone for the differential diagnosis of ischemic ulcers. The toe-brachial pressure index and the pole test represent attractive alternative tests especially in patients with diabetes. Color flow Doppler imaging (CFDI) is advantageous over ABPI in cases in which wounds and ulcers prevent the use of a cuff by virtue of their size or location; additionally CFDI technology can detect nonflow limiting lesions, lesions to nonaxial arteries such as the deep femoral artery, or lesions limited to a single tibial artery. Continued improvements in the accuracy of CFDI have prompted some vascular surgeons to replace contrast arteriography in distal bypass procedures. Transcutaneous partial oxygen tension measurement (TcPO(2)) is another noninvasive method that is reliable to select the level of amputation and recommended to determine tissue viability in critically ischemic limbs and in the management of the diabetic foot. CFDI has revolutionized the diagnostic approach to venous disorders and it is considered the gold standard for the assessment of the venous system of the lower limb, causes minimal inconvenience to patients, and is easily repeatable, but it is considered highly operator dependent. Various plethysmography techniques are of limited application in ulcer investigations, because of their difficulty to calibrate signal, unless time measurements such as the postexercise refilling time are used.

Entities:  

Mesh:

Year:  2007        PMID: 18048871     DOI: 10.1177/1534734607306878

Source DB:  PubMed          Journal:  Int J Low Extrem Wounds        ISSN: 1534-7346            Impact factor:   2.057


  12 in total

1.  The diabetic foot: a global threat and a huge challenge for Greece.

Authors:  N Papanas; E Maltezos
Journal:  Hippokratia       Date:  2009-10       Impact factor: 0.471

2.  Measurement of morphological and physiological skin properties in aged care residents: a test-retest reliability pilot study.

Authors:  Robyn Rayner; Keryln Carville; Gavin Leslie; Satvinder S Dhaliwal
Journal:  Int Wound J       Date:  2016-05-24       Impact factor: 3.315

3.  A large Italian observational multicentre study on vascular ulcers of the lower limbs (Studio Ulcere Vascolari).

Authors:  Alessandro Apollonio; Pier L Antignani; Michelangelo Di Salvo; Giacomo Failla; Giorgio Guarnera; Giovanni Mosti; Elia Ricci
Journal:  Int Wound J       Date:  2014-02-12       Impact factor: 3.315

4.  Oxidative stress mediates chemical hypoxia-induced injury and inflammation by activating NF-κb-COX-2 pathway in HaCaT cells.

Authors:  Chuntao Yang; Hongzhong Ling; Meifen Zhang; Zhanli Yang; Xiuyu Wang; Fanqin Zeng; Chuhuai Wang; Jianqiang Feng
Journal:  Mol Cells       Date:  2011-04-20       Impact factor: 5.034

5.  The evaluation of lower-extremity ulcers.

Authors:  Georgios Spentzouris; Nicos Labropoulos
Journal:  Semin Intervent Radiol       Date:  2009-12       Impact factor: 1.513

6.  Chronic venous ulceration of leg associated with peripheral arterial disease: an underappreciated entity in developing country.

Authors:  Falguni Nag; Abhishek De; Avijit Hazra; Gobinda Chatterjee; Arghyaprasun Ghosh; Trupti V Surana
Journal:  Int Wound J       Date:  2012-11-22       Impact factor: 3.315

7.  Cross-sectional correlations between the toe brachial index and lower limb complications in older people.

Authors:  Jennifer A Sonter; Vivienne H Chuter
Journal:  Int Wound J       Date:  2015-12-09       Impact factor: 3.315

8.  Hydrogen sulfide protects against chemical hypoxia-induced cytotoxicity and inflammation in HaCaT cells through inhibition of ROS/NF-κB/COX-2 pathway.

Authors:  Chuntao Yang; Zhanli Yang; Meifen Zhang; Qi Dong; Xiuyu Wang; Aiping Lan; Fanqin Zeng; Peixi Chen; Chuhuai Wang; Jianqiang Feng
Journal:  PLoS One       Date:  2011-07-14       Impact factor: 3.240

9.  Remifentanil protects human keratinocytes against hypoxia-reoxygenation injury through activation of autophagy.

Authors:  Jae-Young Kwon; Bong-Soo Park; Yong-Ho Kim; Yong-Deok Kim; Cheul-Hong Kim; Ji-Young Yoon; Ji-Uk Yoon
Journal:  PLoS One       Date:  2015-01-23       Impact factor: 3.240

10.  Summary of recommendations for leg ulcers.

Authors:  Sunil Dogra; Rishu Sarangal
Journal:  Indian Dermatol Online J       Date:  2014-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.